D65 vs O67.0
D65 and O67.0 can never be reported together. ICD-10-CM declares them mutually exclusive with an Excludes1 note, meaning the two conditions cannot occur in the same patient — so exactly one of them is correct for any given encounter.
Disseminated intravascular coagulation [defibrination syndrome]
- Chapter 3
- Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
- Section
- D65-D69
- Afibrinogenemia, acquired
- Consumption coagulopathy
- COVID-19 associated diffuse or disseminated intravascular coagulopathy
- Diffuse or disseminated intravascular coagulation [DIC]
- Fibrinolytic hemorrhage, acquired
- Fibrinolytic purpura
- Purpura fulminans
- Defibrination (syndrome)
- Fibrinolysis (hemorrhagic) (acquired)
- Proteolysis, pathologic
- Afibrinogenemia › acquired
- Coagulation, intravascular › COVID-19 associated (diffuse) (disseminated)
Intrapartum hemorrhage with coagulation defect
- Chapter 15
- Pregnancy, childbirth and the puerperium
- Section
- O60-O77
- Intrapartum hemorrhage (excessive) associated with afibrinogenemia
- Intrapartum hemorrhage (excessive) associated with disseminated intravascular coagulation
- Intrapartum hemorrhage (excessive) associated with hyperfibrinolysis
- Intrapartum hemorrhage (excessive) associated with hypofibrinogenemia
- Defibrination › intrapartum (syndrome)
- Fibrinolysis › intrapartum (hemorrhagic) (acquired)
- Defect, defective › coagulation › intrapartum
- Dyscrasia › blood › intrapartum hemorrhage
- Delivery › cesarean › hemorrhage › with coagulation defect (childbirth) (labor)
These two codes sit in different chapters of the Tabular List, which is usually the clearest signal that they describe different underlying processes rather than different degrees of the same one.
Excludes1 is not always absolute: where two conditions covered by the note are genuinely unrelated, CMS guidance permits reporting both. Document the reasoning rather than assuming it. More on Excludes1 vs Excludes2 · FY2027